These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4229020)

  • 1. [Differentiation between fibrinogenolysis and fibrinolysis products induced by plasmin].
    Maki M
    Nihon Ketsueki Gakkai Zasshi; 1967 Apr; 30(2):267-75. PubMed ID: 4229020
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of fibrinolysis and fibrinogenolysis products on thrombocyte adhesiveness].
    Levin GIa; Fisher SI; Mishukova GN
    Probl Gematol Pereliv Krovi; 1973 May; 18(5):33-4. PubMed ID: 4273647
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypofibrinogenemic states in obstetrics.
    Sise HS
    J Reprod Med; 1973 Mar; 10(3):115-7. PubMed ID: 4266545
    [No Abstract]   [Full Text] [Related]  

  • 4. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
    J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
    [No Abstract]   [Full Text] [Related]  

  • 5. Modification of local Shwartzman reaction by drug-induced fibrinolysis.
    Illig L; Schneider K; Winckelmann G; Kunick I; Paul E
    Bibl Anat; 1969; 10():464-8. PubMed ID: 4260174
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of antiplasmin on fibrinolysis and fibrinogenolysis].
    Bratus' GM; Byshevskiĭ ASh
    Ukr Biokhim Zh; 1971; 43(2):178-82. PubMed ID: 4254692
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Influence of plasmin inhibitors on differentiating digestion between fibrinogenolysis and fibrinolysis.
    Abe T; Kazama M
    Thromb Diath Haemorrh; 1975 Nov; 34(2):584. PubMed ID: 53895
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinogen fragment D - inhibitor of fibrinolytic processes].
    Rozenfel'd MA; Fateeva LA; Gontar' ID
    Biokhimiia; 1983 Jul; 48(7):1135-40. PubMed ID: 6225469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study of fibrinogenolysis of adult and cord vein fibrinogen (author's transl)].
    Hafter R; Wallenstätter R; Graeff H
    Hoppe Seylers Z Physiol Chem; 1981 Feb; 362(2):175-8. PubMed ID: 6452398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the proteolysis of fibrinogen and fibrin by Aspergillus ochraceus enzyme as compared to the action of plasmin.
    Teisseyre E; Latallo ZS; Kopeć M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):99-110. PubMed ID: 4134484
    [No Abstract]   [Full Text] [Related]  

  • 13. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Considerations on fibrinolysis with particular reference to a biological inhibitor of plasmin].
    Coelho MC; Tim AR
    Hospital (Rio J); 1968 Jul; 74(1):307-14. PubMed ID: 4238955
    [No Abstract]   [Full Text] [Related]  

  • 15. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.
    Schaefer AV; Leslie BA; Rischke JA; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2006 Apr; 45(13):4257-65. PubMed ID: 16566600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clotting-fibrinolysis in a cavernous hemangioma.
    Hillman RS; Phillips LL
    Am J Dis Child; 1967 Jun; 113(6):649-53. PubMed ID: 4226057
    [No Abstract]   [Full Text] [Related]  

  • 19. Properties of fibrinogenolysis and fibrinolysis products in immune assays.
    Beller FK; Maki M
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):114-32. PubMed ID: 4229208
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunochemical studies of the circulating products of fibrinogenolysis in certain pathological conditions.
    FERRI RG; FERREIRA HC
    Vox Sang; 1963; 8():356-62. PubMed ID: 13944915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.